Download full report with analyst certification and important disclosures
Nov 29 2023, 07:15 GMT
CVS has issued a trading statement, covering the first four months of its H1 2024 to end-October, ahead of its AGM today. Revenue growth and the EBITDA margin are in line with forecasts, which we will be leaving unchanged. M&A activity has been strong and is likely to surpass the annual target.
Nov 29 2023, 07:15 GMT